Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA HCG11 Promotes Colorectal Cancer Cell Malignant Behaviors via Sponging miR-26b-5p. | J Immunol Res | 2023 | 36874625 | PubTator, text mining | PubMed |
| Whole-genome sequencing identified novel mutations in a Chinese family with lynch syndrome. | Front Oncol | 2023 | 36874103 | PubTator, text mining | PubMed |
| Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics. | Front Genet | 2023 | 36873929 | PubTator, text mining | PubMed |
| Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. | Ther Adv Med Oncol | 2023 | 36872946 | PubTator, text mining | PubMed |
| Food insecurity among families with infants born during the COVID-19 pandemic in Fortaleza, Northeast Brazil. | J Health Popul Nutr | 2023 | 36872394 | PubTator, text mining | PubMed |
| Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation. | Genome Biol | 2023 | 36869380 | PubTator, text mining | PubMed |
Retinoblastoma-Binding Protein 5 Regulates H3K4 Methylation Modification to Inhibit the Proliferation of Melanoma Cells by Inactivating the Wnt/β-Catenin and Epithelial-Mesenchymal Transition Pathways. | J Oncol | 2023 | 36866240 | PubTator, text mining | PubMed |
| A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model. | Front Oncol | 2023 | 36865791 | PubTator, text mining | PubMed |
| De novo familial adenomatous polyposis associated thyroid cancer with a c.2929delG frameshift deletion mutation in APC: a case report and literature review. | World J Surg Oncol | 2023 | 36864485 | PubTator, text mining | PubMed |
| Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer. | Front Immunol | 2023 | 36860848 | PubTator, text mining | PubMed |
| Systems Medicine for Precise Targeting of Glioblastoma. | Mol Biotechnol | 2023 | 36859639 | PubTator, text mining | PubMed |
| In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas. | Front Oncol | 2023 | 36845680 | PubTator, text mining | PubMed |
| The role of histone methyltransferases in neurocognitive disorders associated with brain size abnormalities. | Front Neurosci | 2023 | 36845425 | PubTator, text mining | PubMed |
| Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer. | Front Endocrinol (Lausanne) | 2023 | 36843602 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
| DIS3: The Enigmatic Gene in Multiple Myeloma. | Int J Mol Sci | 2023 | 36835493 | PubTator, text mining | PubMed |
| Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation. | Int J Mol Sci | 2023 | 36834572 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Study Suggests an Impact of FANCA, CDH1 and VEGFA Genes on Diffuse Gastric Cancer Development. | Genes (Basel) | 2023 | 36833207 | PubTator, text mining | PubMed |
| Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer. | Cancers (Basel) | 2023 | 36831644 | PubTator, text mining | PubMed |
| Sensitive Detection of Cell-Free Tumour DNA Using Optimised Targeted Sequencing Can Predict Prognosis in Gastro-Oesophageal Cancer. | Cancers (Basel) | 2023 | 36831507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=38